SEL1L a multifaceted protein playing a role in tumor progression

Since the cloning in 1997 of SEL1L, the human ortholog of the sel‐1 gene of C. elegans, most studies have focused on its role in cancer progression and have provided significant evidences to link its increased expression to a decrease in tumor aggressiveness. SEL1L resides on a “Genome Desert area” on chromosome 14q24.3‐31 and is highly conserved in evolution. The function of the SEL1L encoded protein is still very elusive although, several evidences from lower organisms indicate that it plays a major role in protein degradation using the ubiquitin‐proteosome system. SEL1L has a very complex structure made up of modules: genomically it consists of 21 exons featuring several alternative transcripts encoding for putative protein isoforms. This structural complexity ensures protein flexibility and specificity, indeed the protein was found in different sub‐cellular compartments and may turn on a particular transcript in response to specific stimuli. The overall architecture of SEL1L guarantees an exquisite regulation in the expression of the gene. © 2005 Wiley‐Liss, Inc.

[1]  A. Pappo,et al.  Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family. , 2006, American journal of clinical pathology.

[2]  I. Biunno,et al.  SEL1L expression in prostatic intraepithelial neoplasia and adenocarcinoma: an immunohistochemical study , 2006, Histopathology.

[3]  T. E. Hinds Diseases , 2021, Modeling Biological Systems.

[4]  D. Delia,et al.  SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactions. , 2005, Neoplasia.

[5]  Aaron S. Gajadhar,et al.  A High Throughput Screen to Identify Substrates for the Ubiquitin Ligase Rsp5* , 2005, Journal of Biological Chemistry.

[6]  S. Kamauchi,et al.  Gene expression in response to endoplasmic reticulum stress in Arabidopsis thaliana , 2005, The FEBS journal.

[7]  S. Ménard,et al.  Protein profile changes in the human breast cancer cell line MCF‐7 in response to SEL1L gene induction , 2005, Proteomics.

[8]  Mary K. Lewinski,et al.  Genome-Wide Analysis of Chromosomal Features Repressing Human Immunodeficiency Virus Transcription , 2005, Journal of Virology.

[9]  N. Gaiano,et al.  Notch signaling in the mammalian central nervous system: insights from mouse mutants , 2005, Nature Neuroscience.

[10]  Ulrich Wagner,et al.  Genome‐wide analysis of the unfolded protein response in fibroblasts from congenital disorders of glycosylation type‐I patients , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  P. Richardson,et al.  Proteasome inhibition as a novel therapeutic target in human cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Stuart K. Calderwood,et al.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications , 2005, Cell stress & chaperones.

[13]  J. Califano,et al.  Impact of Chromosome 14 q Loss on Survival in Primary Head and Neck Squamous Cell Carcinoma , 2005 .

[14]  M. Stefani Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. , 2004, Biochimica et biophysica acta.

[15]  P. Hu,et al.  Critical Role of Endogenous Akt/IAPs and MEK1/ERK Pathways in Counteracting Endoplasmic Reticulum Stress-induced Cell Death* , 2004, Journal of Biological Chemistry.

[16]  Kathryn L. Lipson,et al.  High ER stress in beta-cells stimulates intracellular degradation of misfolded insulin. , 2004, Biochemical and biophysical research communications.

[17]  Patrick Maisonneuve,et al.  Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.

[18]  D. Antonello,et al.  Identification of a novel polymorphism in the fibronectin type II domain of the SEL1L gene and possible relation to the persistent hyperinsulinemic hypoglycemia of infancy. , 2004, Mutation research.

[19]  K. Politi,et al.  Notch in mammary gland development and breast cancer. , 2004, Seminars in cancer biology.

[20]  S. Bosari,et al.  SEL1L and Squamous Cell Carcinoma of the Esophagus , 2004, Clinical Cancer Research.

[21]  I. Biunno,et al.  RNA-mediated interference indicates that SEL1L plays a role in pancreatic beta-cell growth. , 2004, DNA and cell biology.

[22]  K. Chin,et al.  In situ analyses of genome instability in breast cancer , 2004, Nature Genetics.

[23]  L. Whitesell,et al.  Altered Hsp90 function in cancer: a unique therapeutic opportunity. , 2004, Molecular cancer therapeutics.

[24]  M. Grütter,et al.  The crystal structure of Helicobacter cysteine-rich protein C at 2.0 A resolution: similar peptide-binding sites in TPR and SEL1-like repeat proteins. , 2004, Journal of molecular biology.

[25]  H. Moch,et al.  [Pediatric renal cell carcinoma]. , 2004, Der Pathologe.

[26]  H. Moch,et al.  Nierenzellkarzinome bei jungen Patienten , 2004, Der Pathologe.

[27]  Edward M. Rubin,et al.  Megabase deletions of gene deserts result in viable mice , 2004, Nature.

[28]  K. Hoang-Xuan,et al.  Loss of 14q Chromosome in Oligodendroglial and Astrocytic Tumors , 2004, Journal of Neuro-Oncology.

[29]  Salvatore Pece,et al.  Endocytosis and cancer. , 2004, Current opinion in cell biology.

[30]  A. Koromilas,et al.  Control of Tumor Suppressor p53 Function by Endoplasmic Reticulum Stress , 2004, Cell cycle.

[31]  Nicola J. Rinaldi,et al.  Control of Pancreas and Liver Gene Expression by HNF Transcription Factors , 2004, Science.

[32]  I. Biunno,et al.  Identification of a region within SEL1L protein required for tumour growth inhibition. , 2004, Gene.

[33]  E. Stavridi,et al.  p53 and stress in the ER. , 2004, Genes & development.

[34]  V. Chau,et al.  Human HRD1 Is an E3 Ubiquitin Ligase Involved in Degradation of Proteins from the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.

[35]  N. Blin,et al.  Promoter selection for the cytosine deaminase suicide gene constructs in gastric cancer , 2004, European journal of gastroenterology & hepatology.

[36]  S. Wagner,et al.  Differential downregulation of endoplasmic reticulum-residing chaperones calnexin and calreticulin in human metastatic melanoma. , 2004, Cancer letters.

[37]  Y. Nomura,et al.  ER signaling in unfolded protein response. , 2003, Life sciences.

[38]  H. Edlund,et al.  Fgf10 maintains notch activation, stimulates proliferation, and blocks differentiation of pancreatic epithelial cells , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[39]  Somasekar Seshagiri,et al.  The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. , 2003, Genome research.

[40]  B. Osborne,et al.  Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents , 2003, Oncogene.

[41]  S. Ménard,et al.  SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivo , 2003, Oncogene.

[42]  N. Blin,et al.  Assessing optimal promoter activity for constructs in gastrointestinal gene therapy. , 2003, Anticancer research.

[43]  Ruedi Aebersold,et al.  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.

[44]  D. Wolf,et al.  For whom the bell tolls: protein quality control of the endoplasmic reticulum and the ubiquitin–proteasome connection , 2003, The EMBO journal.

[45]  Jeffrey L. Wrana,et al.  Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.

[46]  Larry Kedes,et al.  HES and HERP families: Multiple effectors of the notch signaling pathway , 2003, Journal of cellular physiology.

[47]  Thomas E. Willnow,et al.  Functional interaction of megalin with the megalinbinding protein (MegBP), a novel tetratrico peptide repeat-containing adaptor molecule , 2003, Journal of Cell Science.

[48]  J. Wrana,et al.  Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. , 2003, Nature cell biology.

[49]  R. Kaufman Orchestrating the unfolded protein response in health and disease. , 2002, The Journal of clinical investigation.

[50]  D. Ron,et al.  Translational control in the endoplasmic reticulum stress response. , 2002, The Journal of clinical investigation.

[51]  G. Sherbet,et al.  Notch signal transduction is not regulated by SEL1L in leukaemia and lymphoma cells in culture. , 2002, Anticancer research.

[52]  M. Kressel,et al.  Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15. , 2002, Human molecular genetics.

[53]  M. Kiraly,et al.  A survival pathway for Caenorhabditis elegans with a blocked unfolded protein response , 2002, The Journal of cell biology.

[54]  E. Dees,et al.  The role of the ubiquitination-proteasome pathway in breast cancer: Applying drugs that affect the ubiquitin-proteasome pathway to the therapy of breast cancer , 2002, Breast Cancer Research.

[55]  R. Hampton ER-associated degradation in protein quality control and cellular regulation. , 2002, Current opinion in cell biology.

[56]  H. Ng,et al.  High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours , 2002, British Journal of Cancer.

[57]  M. Campiglio,et al.  Production of a monoclonal antibody directed against the recombinant SEL1L protein. , 2002 .

[58]  S. Ying,et al.  Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin 1 , 2002, Experimental biology and medicine.

[59]  S. Ménard,et al.  SEL1L expression decreases breast tumor cell aggressiveness in vivo and in vitro. , 2002, Cancer research.

[60]  I. Rogozin,et al.  Cross-species conservation of SEL1L, a human pancreas-specific expressing gene. , 2002, Omics : a journal of integrative biology.

[61]  S. Ménard,et al.  SEL 1 L Expression Decreases Breast Tumor Cell Aggressiveness in Vivo and in Vitro 1 , 2002 .

[62]  S. Ménard,et al.  Allelic polymorphisms in the transcriptional regulatory region of human SEL1L. , 2001, Mutation research.

[63]  F. Pociot,et al.  Complete mutation scanning of the human SEL 1L gene: a candidate gene for type 1 diabetes , 2001, Acta Diabetologica.

[64]  J. Buchner,et al.  Hsp90: Chaperoning signal transduction , 2001, Journal of cellular physiology.

[65]  F. Pociot,et al.  No evidence for SEL1L as a candidate gene for IDDM11‐conferred susceptibility , 2001, Diabetes/metabolism research and reviews.

[66]  Serge Lemay,et al.  The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin* , 2001, The Journal of Biological Chemistry.

[67]  M. Asashima,et al.  Activin A induces expression of rat Sel-1l mRNA, a negative regulator of notch signaling, in rat salivary gland-derived epithelial cells. , 2001, Biochemical and biophysical research communications.

[68]  Jonathan Boyd,et al.  The hairpin structure of the 6F11F22F2 fragment from human fibronectin enhances gelatin binding , 2001, The EMBO journal.

[69]  T. Yanagawa,et al.  SEL1L microsatellite polymorphism in Japanese patients with autoimmune thyroid diseases. , 2001, Thyroid : official journal of the American Thyroid Association.

[70]  I. Rogozin,et al.  Cloning and functional analysis of SEL1L promoter region, a pancreas-specific gene. , 2001, DNA and cell biology.

[71]  R. Lothe,et al.  Identification of two potential suppressor gene regions on chromosome arm 14q that are commonly lost in advanced colorectal carcinomas. , 2001, Scandinavian journal of gastroenterology.

[72]  C. Ponting Proteins of the endoplasmic-reticulum-associated degradation pathway: domain detection and function prediction. , 2000, The Biochemical journal.

[73]  O. Volpert,et al.  Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[74]  M. Sudol,et al.  The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  S. Ménard,et al.  The Expression of Sel1L and Tan-1 in Normal and Neoplastic Cells , 2000, The International journal of biological markers.

[76]  P. Dear,et al.  SEL1L, the human homolog of C. elegans sel-1: refined physical mapping, gene structure and identification of polymorphic markers , 2000, Human Genetics.

[77]  B. Osborne,et al.  Arbiter of differentiation and death: Notch signaling meets apoptosis , 1999, Journal of cellular physiology.

[78]  G. Blatch,et al.  The tetratricopeptide repeat: a structural motif mediating protein-protein interactions. , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[79]  A. Tanigami,et al.  Complete cDNA sequence and genomic organization of a human pancreas-specific gene homologous to Caenorhabditis elegans sel-1 , 1999, Journal of Human Genetics.

[80]  G. Kovacs,et al.  Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. , 1999, The American journal of surgical pathology.

[81]  S. Artavanis-Tsakonas,et al.  Notch Signaling : Cell Fate Control and Signal Integration in Development , 1999 .

[82]  A. Bernstein,et al.  Cloning and characterization of Sel-1l, a murine homolog of the C. elegans sel-1 gene , 1998, Mechanisms of Development.

[83]  F. Gago,et al.  Heat shock protein expression and drug resistance in breast cancer patients treated with induction chemotherapy , 1998, International journal of cancer.

[84]  I. Greenwald,et al.  LIN-12/Notch signaling: lessons from worms and flies. , 1998, Genes & development.

[85]  I. Fentiman,et al.  Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients. , 1998, European Journal of Cancer.

[86]  D. Barford,et al.  The structure of the tetratricopeptide repeats of protein phosphatase 5: implications for TPR‐mediated protein–protein interactions , 1998, The EMBO journal.

[87]  V. Sgaramella,et al.  Isolation of a pancreas-specific gene located on human chromosome 14q31: expression analysis in human pancreatic ductal carcinomas. , 1997, Genomics.

[88]  S. Artavanis-Tsakonas,et al.  Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2 , 1997, Molecular and cellular biology.

[89]  W. Richards,et al.  The tetratricopeptide repeat containing Tg737 gene is a liver neoplasia tumor suppressor gene , 1997, Oncogene.

[90]  W. Poon,et al.  Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas. , 1997, Human pathology.

[91]  S. Goodman,et al.  Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.

[92]  D. Gallahan,et al.  The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4) , 1997, Oncogene.

[93]  W. Richards,et al.  Isolation and characterization of liver epithelial cell lines from wild-type and mutant TgN737Rpw mice. , 1997, The American journal of pathology.

[94]  J. Califano,et al.  Impact of chromosome 14q loss on survival in primary head and neck squamous cell carcinoma. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[95]  I. Greenwald,et al.  Structure, function, and expression of SEL-1, a negative regulator of LIN-12 and GLP-1 in C. elegans. , 1997, Development.

[96]  D. Slamon,et al.  Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Δ11b , 1997, Oncogene.

[97]  Suna Wang,et al.  Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms. , 1996, Oncogene.

[98]  J. Rine,et al.  Role of 26S proteasome and HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase, an integral endoplasmic reticulum membrane protein. , 1996, Molecular biology of the cell.

[99]  Kathleen R. Cho,et al.  DPC4 gene in various tumor types. , 1996, Cancer research.

[100]  I. Greenwald,et al.  The Caenorhabditis elegans sel-1 gene, a negative regulator of lin-12 and glp-1, encodes a predicted extracellular protein. , 1996, Genetics.

[101]  J. Sklar,et al.  Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles , 1996, The Journal of experimental medicine.

[102]  R. Coombes,et al.  Inhibitory effects of activin on the growth and morpholgenesis of primary and transformed mammary epithelial cells. , 1996, Cancer research.

[103]  J. Sklar,et al.  TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.